These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11778267)

  • 1. [The relationship between sensitivity to arsenic trioxide and antioxidative capacity of malignant hematopoietic cells].
    Zhu Q; Chen G; Huang Y
    Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):359-61. PubMed ID: 11778267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system.
    Dai J; Weinberg RS; Waxman S; Jing Y
    Blood; 1999 Jan; 93(1):268-77. PubMed ID: 9864170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The mechanisms of arsenic trioxide-induced apoptosis in hematopoietic malignant cells].
    Cai X; Chen G; Jia P
    Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):452-5. PubMed ID: 11715442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway.
    Jing Y; Dai J; Chalmers-Redman RM; Tatton WG; Waxman S
    Blood; 1999 Sep; 94(6):2102-11. PubMed ID: 10477740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4.
    Bernardini S; Nuccetelli M; Noguera NI; Bellincampi L; Lunghi P; Bonati A; Mann K; Miller WH; Federici G; Lo Coco F
    Ann Hematol; 2006 Oct; 85(10):681-7. PubMed ID: 16733740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glutathione synthesis inhibitor enhances arsenic trioxide-induced apoptosis].
    Shen Y; Chen G; Cai X
    Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):259-61. PubMed ID: 11776809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance.
    Lehmann S; Bengtzen S; Paul A; Christensson B; Paul C
    Eur J Haematol; 2001 Jun; 66(6):357-64. PubMed ID: 11488934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines.
    Lu M; Levin J; Sulpice E; Sequeira-Le Grand A; Alemany M; Caen JP; Han ZC
    Exp Hematol; 1999 May; 27(5):845-52. PubMed ID: 10340400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of four arsenic antagonists on apoptosis and telomerase activity induced by arsenic trioxide in three myelocytic leukemia cell lines.
    Wei YM; Ou YX; Bai H; Lu JH; Zheng RL
    Acta Pharmacol Sin; 2001 Aug; 22(8):725-30. PubMed ID: 11749846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Potentiation of arsenic trioxide-induced apoptosis by retinoic acid in retinoic acid sensitive and resistant HL-60 myeloid leukemia cells].
    Huang X
    Chin Med J (Engl); 2000 Jun; 113(6):498-501. PubMed ID: 11775865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
    Giri U; Terry NH; Kala SV; Lieberman MW; Story MD
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of intracellular arsenic trioxide for therapeutic response in acute promyelocytic leukemia.
    Sahu GR; Jena RK
    Am J Hematol; 2005 Feb; 78(2):113-6. PubMed ID: 15682419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arsenic trioxide combined with buthionine sulfoximine enhances apoptosis in multidrug-resistant human leukemia K562/ADM cells in vitro].
    Wang T; Ma LM; Zhang HP; Wang HW; Yang LH; Qiao ZH
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):188-91. PubMed ID: 18756933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide circumvents multidrug resistance based on different mechanisms in human leukemia cell lines.
    Seo T; Urasaki Y; Takemura H; Ueda T
    Anticancer Res; 2005; 25(2A):991-8. PubMed ID: 15868938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level.
    Cheng B; Yang X; An L; Gao B; Liu X
    Auris Nasus Larynx; 2010 Feb; 37(1):89-94. PubMed ID: 19574005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells.
    Chen GQ; Zhou L; Styblo M; Walton F; Jing Y; Weinberg R; Chen Z; Waxman S
    Cancer Res; 2003 Apr; 63(8):1853-9. PubMed ID: 12702573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of leukemic T-cell lines to arsenic trioxide cytotoxicity is dependent on the induction of phosphatase B220/CD45R expression at the cell surface.
    Benbijja M; Mellouk A; Bobé P
    Mol Cancer; 2014 Nov; 13():251. PubMed ID: 25410152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting catalase but not peroxiredoxins enhances arsenic trioxide-induced apoptosis in K562 cells.
    Song LL; Tu YY; Xia L; Wang WW; Wei W; Ma CM; Wen DH; Lei H; Xu HZ; Wu YL
    PLoS One; 2014; 9(8):e104985. PubMed ID: 25115845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of arsenic trioxide-induced cytotoxicity on multiple myeloma cells].
    Chen YB; Hou J; Fu WJ; Ding SQ; Wang DX; Yuan ZG; Kong XT
    Ai Zheng; 2003 Dec; 22(12):1276-9. PubMed ID: 14693051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalase activity and arsenic sensitivity in acute leukemia.
    Coe E; Schimmer AD
    Leuk Lymphoma; 2008 Oct; 49(10):1976-81. PubMed ID: 18949620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.